FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial
FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps.
Source: news-medical.net